About Select ImmunoGenomics
Select ImmunoGenomics is a company based in Chapel Hill (United States) founded in 2016 was acquired by GeneCentric in August 2019.. Select ImmunoGenomics offers products and services including PurIST Test, EXpressCT, and TRIUMPH AI Diagnostics. Select ImmunoGenomics operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
- Headquarter Chapel Hill, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
GeneCentric
(Aug 15, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Select ImmunoGenomics
Select ImmunoGenomics offers a comprehensive portfolio of products and services, including PurIST Test, EXpressCT, and TRIUMPH AI Diagnostics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Identifies pancreatic cancer treatment responses using RNA signatures
Provides liquid biopsy platform for cancer genomic analysis
Applies AI to develop cancer response signatures
Funding Insights of Select ImmunoGenomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Select ImmunoGenomics
Select ImmunoGenomics has secured backing from 1 investor. Prominent investors backing the company include GeneCentric. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diagnostics for cancer classification and treatment are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Select ImmunoGenomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Select ImmunoGenomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Select Immunogenomics Comparisons
Competitors of Select ImmunoGenomics
Select ImmunoGenomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
AI-based omics data analysis solutions are provided to researchers.
|
|
| domain | founded_year | HQ Location |
Developer of predictive informatics based platform for drug discovery
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Select ImmunoGenomics
When was Select ImmunoGenomics founded?
Select ImmunoGenomics was founded in 2016.
Where is Select ImmunoGenomics located?
Select ImmunoGenomics is headquartered in Chapel Hill, United States. It is registered at Chapel Hill, North Carolina, United States.
What does Select ImmunoGenomics do?
Select ImmunoGenomics was founded in 2016 and is based in Chapel Hill, United States. Operations focus on the bioinformatics sector, where an integrated platform is offered to support genomic studies. Services encompass data analysis, predictive modeling, and reporting, which aid in biomarker development and validation. These capabilities are utilized by researchers and organizations in the life sciences field.
Who are the top competitors of Select ImmunoGenomics?
Select ImmunoGenomics's top competitors include Helix, Benchling and BioAge Labs.
What products or services does Select ImmunoGenomics offer?
Select ImmunoGenomics offers PurIST Test, EXpressCT, and TRIUMPH AI Diagnostics.
Who are Select ImmunoGenomics's investors?
Select ImmunoGenomics has 1 investor. Key investors include GeneCentric.